Delivery Order SPE2DB20D3103-SPE2DB25FM4M3

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,198.97 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award, valued at $3,511.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is a delivery order placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.96 firm-fixed-price delivery order is for the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.26 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,433.28 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, with a completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,881.92, is a delivery order for the supply of 4566938015 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The award has an ultimate completion date of January 15, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,508.49 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, with a completion date of January 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,634.62 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,425.12 firm fixed-price delivery order is for TELMISARTAN 80 MG TABLET 30S, with a completion date of January 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,620.00 Firm Fixed Price Delivery Order contract is for the supply of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of July 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM4M3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,613.68 firm fixed-price delivery order is for the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. This IDC, which runs through November 2026, covers critical medical commodities across multiple therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract does not have a set-aside designation, indicating open competition.

Generated 4/25/25, 10:19 AM